DUBLIN--(BUSINESS WIRE)--The "Global Pneumonia Therapeutics Market 2017-2021" report has been added to Research and Markets' offering.
The report forecasts the global pneumonia therapeutics market to grow at a CAGR of 6.66% during the period 2017-2021 .
The report, Global Pneumonia Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is strong pipeline. The pipeline molecules in the respiratory disorder drugs market are rising at a good pace as consistent funding opportunity for R&D are available, and it is expected to fuel the market growth during the forecast period. For example, one of the popular funding bodies, Bill & Melinda Gates Foundation is supporting a new vaccine development by providing financial aid to combat pneumococcal disease in neonates.
According to the report, one of the major drivers for this market is increased awareness about prophylaxis by vaccines. The awareness about prophylaxis has increased significantly in the past few years, and as a result, the world population is preferring to opt for preventive measures to reduce the possibility of disease onset. Preference to prevent pneumonia works as growth booster for the pneumonia vaccine market. Federal bodies also contribute significantly to awareness-raising campaigns. For instance, the National Institutes of Health (NIH) recommends regular pneumococcal vaccinations in its clinical guidelines for geriatric patients and patients at high risk for pneumonia. Such recommendations help population become aware of prophylaxis treatments thereby, driving the growth of the pneumonia therapeutics market.
Key vendors
- GlaxoSmithKline
- Merck Sharp & Dohme
- Novartis
- Pfizer
Other prominent vendors
- AstraZeneca
- Bayer
- Biotest
- Ono Pharmaceutical
- Tetraphase Pharmaceuticals
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Disease Overview
Part 06: Market Ecosystem
Part 07: Market Sizing
Part 08: Pipeline Analysis
Part 09: Five Forces Analysis
Part 10: Market Segmentation By Product Type
Part 11: Market Segmentation By Pneumonia Type
Part 12: Regional Landscape
Part 13: Decision Framework
Part 14: Drivers And Challenges
Part 15: Market Trends
Part 16: Vendor Landscape
Part 17: Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/7xcmwb/global_pneumonia
